Raphael Pharmaceutical Income Statement (2020-2025) | RAPH

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
0.17M0.22M0.16M0.22M0.09M0.08M0.33M0.68M0.11M0.29M0.51M-0.35M0.38M0.02M0.16M0.21M
Selling, General & Administrative (Quarter)
0.08M0.16M0.26M0.35M0.09M0.53M1.09M0.43M0.14M0.13M0.22M0.27M0.17M0.23M0.16M0.18M
Operating Expenses (Quarter)
0.25M0.39M0.42M0.57M0.17M0.61M1.43M1.10M0.26M0.42M0.73M-0.07M0.55M0.25M0.32M0.39M
Operating Income (Quarter)
-0.25M-0.39M-0.42M-0.57M-0.17M-0.61M-1.43M-1.10M-0.26M-0.42M-0.73M0.13M-0.55M-0.25M-0.32M-0.39M
EBIT (Quarter)
-0.25M-0.39M-0.42M-0.57M-0.17M-0.61M-1.43M-1.10M-0.26M-0.42M-0.73M0.13M-0.55M-0.25M-0.32M-0.39M
Non-operating items
Non Operating Income (Quarter)
-0.00M-0.00M0.00M0.01M-0.01M-0.01M-0.02M0.00M-0.01M0.00M0.00M-0.01M-0.00M0.00M-0.01M-0.00M
Net income details
EBT (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Profit After Tax (Quarter)
-0.26M-0.39M-0.42M-0.57M-0.18M-0.63M-1.44M-1.10M-0.26M-0.42M-0.72M0.12M-0.55M-0.25M-0.33M-0.40M
Income from Continuing Operations (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Consolidated Net Income (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Income towards Parent Company (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Net Income towards Common Stockholders (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Additional items
EPS (Basic) (Quarter)
-0.03-0.04-0.03-0.16-0.01-0.04-0.09-0.13-0.02-0.03-0.04-0.07-0.03-0.01-0.02-0.10
EPS (Diluted) (Quarter)
-0.04-0.03-0.16-0.01-0.04-0.09-0.13-0.02-0.03-0.04-0.07-0.03-0.01-0.02-0.10
Shares Outstanding (Quarter)
9.46M10.81M12.13M11.17M13.04M13.65M15.06M14.34M15.96M16.11M16.44M16.72M18.62M18.68M18.70M18.67M19.63M19.63M19.63M19.55M
Shares Outstanding (Diluted) (Quarter)
10.81M12.13M11.17M13.04M13.65M15.06M14.34M15.96M16.11M16.44M16.72M18.62M18.68M18.70M18.67M19.63M19.63M19.63M19.55M
EBITDA (Quarter)
-0.25M-0.39M-0.42M-0.57M-0.17M-0.61M-1.43M-1.10M-0.26M-0.42M-0.73M0.13M-0.55M-0.25M-0.32M-0.39M
Interest Expenses (Quarter)
1.24M0.73M1.27M1.54M1.99M